scispace - formally typeset
B

Byeong Hyeon Choi

Researcher at Korea University

Publications -  31
Citations -  391

Byeong Hyeon Choi is an academic researcher from Korea University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 6, co-authored 20 publications receiving 138 citations. Previous affiliations of Byeong Hyeon Choi include KAIST.

Papers
More filters
Journal ArticleDOI

Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes.

TL;DR: An accurate diagnosis of early-stage lung cancer is demonstrated, using deep learning-based surface-enhanced Raman spectroscopy of the exosomes of cells derived from normal and lung cancer cell lines, with an accuracy of 95%.
Journal ArticleDOI

Intraoperative pulmonary neoplasm identification using near-infrared fluorescence imaging.

TL;DR: NIR fluorescence imaging could safely identify pulmonary neoplasms after the systemic injection of ICG, and low-dose ICG is sufficient for NIRfluorescence imaging of pulmonary neplasms.
Journal ArticleDOI

Evaluation of Intraoperative Near-Infrared Fluorescence Visualization of the Lung Tumor Margin With Indocyanine Green Inhalation.

TL;DR: The results of this study suggest that lung-specific inhalation delivery of ICG is feasible and may be useful for the intraoperative visualization of lung tumor margin in clinical practice.
Journal ArticleDOI

Fluorescent and Iodized Emulsion for Preoperative Localization of Pulmonary Nodules.

TL;DR: A fluorescent iodized emulsion prepared by mixing ICG with lipiodol enabled accurate localization and resection of pulmonary nodules and had the best consistency in the rabbit lungs.
Journal ArticleDOI

Poly(lactic-co-glycolic acid) microparticles in fibrin glue for local, sustained delivery of bupivacaine

TL;DR: The FG_BPC-MPs loaded with bupivacaine can be a promising formulation for the treatment of local, persistent pain after surgery and a dramatic increase in paw withdrawal threshold was observed during the entire 10-day testing period, suggesting that the pain-relief efficacy was improved and prolonged compared with that for the other control formulations.